| ADHD | Attention-Deficit/Hyperactivity Disorder |
| ASD | Autism Spectrum Disorder |
| ASRS | Adult ADHD Self-Report Scale |
| ATX | Atomoxetine |
| AUD | Alcohol Use Disorder |
| BPRS-6 | Six-item Brief Psychiatric Rating Scale |
| BRI | Behavioral Regulation Index |
| BRIEF-A | Behavior Rating Inventory of Executive Function—Adult Version |
| CAARS-O:SV | Conners’ Adult ADHD Rating Scale—Observer Report: Screening Version |
| CGI-I | Clinical Global Impression—Improvement scale |
| CI | Confidence Interval |
| CUD | Cannabis Use Disorder |
| DAT | Dopamine Transporter |
| DIVA-5 | Diagnostic Interview for ADHD in Adults, version 5 |
| DSM-5-TR | Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision |
| DSM-5 | Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition |
| DSP | Delayed Sleep Phase profile |
| HAM-D | Hamilton Depression Rating Scale |
| HED | Higher Emotional Dysregulation |
| LED | Lower Emotional Dysregulation |
| MEQ | Morningness–Eveningness Questionnaire |
| MI | Metacognition Index |
| MPH | Methylphenidate |
| OR | Odds Ratio |
| OUD | Opioid Use Disorder |
| RIPoSt-40 | Reactivity, Intensity, Polarity and Stability questionnaire |
| SCID-5 | Structured Clinical Interview for DSM-5 |
| SUD | Substance Use Disorder |
| THC | Δ9-tetrahydrocannabinol |
| YMRS | Young Mania Rating Scale |